NASDAQ:OM
Outset Medical, Inc.
Outset Medical, Inc.'s revenue grew 5.1% in fiscal 2025 to $119.5M while operating margin rose to −55.8%, its highest in 8 years. Free cash flow was −$47.1M, −39.4% of revenue, and the diluted share count rose 339.2%.Summary generated from Outset Medical, Inc.'s SEC filings. Latest annual report filed Feb 13, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$119.5M
Revenue growth+5.1%
Revenue, 5-yr CAGR+19.1%
Gross margin39.1%
Operating margin−55.8%
Net margin−68.3%
ROIC−36.5%
Return on equity−106.2%
Debt / equity0.76
Free cash flow−$47.1M
FCF margin−39.4%
Share count change+339.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 103 | 115 | 130 | 114 | 119 |
| Operating income | −131 | −161 | −170 | −113 | −67 |
| Net income | −132 | −163 | −173 | −128 | −82 |
| Free cash flow | −133 | −154 | −135 | −117 | −47 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 8-KDirector or officer change
Aug 28, 2026 - 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KEntry into a material agreement
Jun 17, 2026 - 8-KResults of a shareholder vote
Jun 5, 2026 - 8-KDirector or officer change
May 29, 2026